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Abstract
Lifestyle interventions such as diet, exercise, and cognitive training represent a quietly emerging revolution in the modern
approach to counteracting age-related declines in brain health. Previous studies in our laboratory have shown that long-
term dietary supplementation with antioxidants and mitochondrial cofactors (AOX) or behavioral enrichment with social,
cognitive, and exercise components (ENR), can effectively improve cognitive performance and reduce brain pathology of
aged canines, including oxidative damage and Ab accumulation. In this study, we build on and extend our previous findings
by investigating if the interventions reduce caspase activation and ceramide accumulation in the aged frontal cortex, since
caspase activation and ceramide accumulation are common convergence points for oxidative damage and Ab, among other
factors associated with the aged and AD brain. Aged beagles were placed into one of four treatment groups: CON – control
environment/control diet, AOX– control environment/antioxidant diet, ENR – enriched environment/control diet, AOX/ENR–
enriched environment/antioxidant diet for 2.8 years. Following behavioral testing, brains were removed and frontal cortices
were analyzed to monitor levels of active caspase 3, active caspase 9 and their respective cleavage products such as tau and
semaphorin7a, and ceramides. Our results show that levels of activated caspase-3 were reduced by ENR and AOX
interventions with the largest reduction occurring with combined AOX/ENR group. Further, reductions in caspase-3
correlated with reduced errors in a reversal learning task, which depends on frontal cortex function. In addition, animals
treated with an AOX arm showed reduced numbers of cells expressing active caspase 9 or its cleavage product semaphorin
7A, while ENR (but not AOX) reduced ceramide levels. Overall, these data demonstrate that lifestyle interventions curtail
activation of pro-degenerative pathways to improve cellular health and are the first to show that lifestyle interventions can
regulate caspase pathways in a higher animal model of aging.
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Introduction
Aging is characterized by cognitive decline, synaptic dysfunction,
and the accumulation of brain pathology. Lifestyle interventions
such as diet, exercise, and cognitive training have emerged as
effective strategies to prevent cognitive decline and reduce brain
pathology [1,2,3]. However, how these lifestyle interventions
improve the health of the aging brain remains unclear.
For several years now, our group has used the aged canine to
study the specific effects of lifestyle interventions on brain aging
and cognitive function. Like aged humans, the aged canine brain
naturally shows cognitive decline, increased oxidative damage,
mitochondrial dysfunction, selective neuron loss, and beta-amyloid
(Ab) accumulation [4]. We have demonstrated that long-term (2.8
years) behavioral enrichment (with social, cognitive, and exercise
stimulation), dietary supplementation (with antioxidants and
mitochondrial cofactors), or the combination of the behavioral
and dietary interventions slow age-related cognitive decline and
reduce brain pathology in aged canines [4,5,6]. The combination
treatment was particular effective in improving cognitive perfor-
mance [4], suggesting that the effects of the behavioral and dietary
treatment approaches are additive.
Mitochondrial dysfunction, oxidative damage and Ab accumu-
lation are thought to be primary factors contributing to declining
function in aging and Alzheimer’s disease (AD) [7]. We have
evaluated these mechanisms as potential targets of the behavioral
anddietary interventions, and foundprominent effectsonimproving
mitochondrial function and reducing oxidative stress. Notably, the
interventions improved mitochondrial NADH respiration, reduced
generation of mitochondrial reactive oxygen species (ROS) [8]
lowered levels of protein carbonyls, and bolstered antioxidant
defense mechanisms in the brain [9]. The reduction in oxidative
damage correlated with cognitive improvement [9], suggesting
that accumulating oxidative stress is likely to be a central feature
underlying cognitive decline in aging. In parallel with reducing
oxidative damage, the behavioral and dietary interventions
modestly reduced the accumulation of Ab in the aged canine brain,
particularly with the combined intervention [10]. Surprisingly,
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cortices, improvements in cognitive performance did not correlate
with Ab load [10], suggesting that effects on Ab are likely not a
central mechanism underlying the cognitive benefits of the
interventions. However, because Ab is well established to
compromise neuronal health and synaptic function [11,12],
accumulation of Ab in the aged canine brain is likely not benign,
and it must be considered that AB may trigger downstream
mechanismsthatcontributetodeclinesinbrainhealthand cognitive
function with age.
It is likely that the combined effects of oxidative stress, impaired
mitochondrial function and AB accumulation can propagate
harmful cascades that converge on common downstream mecha-
nisms that ultimately cause neuronal damage and dysfunction. Two
downstream targets that have recently come into increasing focus
for their roles in compromising synaptic function and cognition are
activated caspase 3 and the bioactive lipid ceramide. While caspases
arebest knownfor their role inapoptosis,recent evidenceimplicates
caspase 3 in non-apoptotic processes, including impairing synaptic
plasticity [13], spine atrophy and degeneration [14,15], and
memory deficits [14] in the absence of neuron loss. In addition,
caspase 3 mediates some of the harmful effectsofcertainpathologies
suchas Ab, asinhibitionof longtermpotentiation (LTP) byAb1–42
is dependent on caspase 3 activation [13]. Like caspase 3, ceramides
have recently been identified as potential causes of cognitive decline
and onset of AD. Ceramide levels are elevated in the brain even at
the earliest clinical stages of AD [16], and there is evidence that
ceramide in CSF and serum may be a useful biomarker predicting
cognitive decline [17]. These signaling molecules are important in
an array of physiological processes and are generated in response to
inflammatory cytokines and oxidative stress either by hydrolysis
of sphingomyelin or by de novo synthesis [18,19]. One effect
of ceramide is to suppress the mitochondrial respiratory chain,
resulting in increased production of ROS and oxidative stress [20].
Oxidative stress, in turn, can activate caspase 3 [21,22,23], and
stimulate ceramide generation [24] revealing that oxidative stress,
ceramides, and caspase 3 are linked in a self-perpetuating feed-
forward cycle. Taken together, this literature suggests that oxidative
damage, mitochondrial dysfunction and AB might ultimately
converge on caspase 3 to impair synaptic and cognitive function.
In this study, we build on our previous findings that long-term
behavioral enrichment, dietary supplementation, or the combined
therapies improve cognitive function, improve mitochondrial
health and function, reduce oxidative damage, and decrease AB
in the aged canine brain. Using this same set of dog tissue, here we
investigate if caspase activation and ceramide accumulation are
reduced in the aged frontal cortex, serving as potential readout
targets of intervention efficacy. In particular, we focus on caspase 3,
based on its recently identified role in driving synaptic dysfunction
in mouse models of AD. We assess if dietary, behavioral, or the
combined interventions reduce the extent of caspase 3 activation in
the aged canine frontal cortex, and assess potential roles of caspases
8 and 9 in mediating the effects of the interventions on caspase 3. In
parallel, we assess levels of several species of ceramides, candidate
risk factors for triggering pathological cascades and cognitive
impairment in the aging brain.
Results
Activated caspase 3 is reduced with ENR, AOX, or
combined intervention
To evaluate if behavioral enrichment (ENR), dietary enrich-
ment (AOX), or the combined intervention (ENR/AOX) affected
the extent of caspase 3 activation in the frontal cortex, cells
immune-positive for activated caspase 3 were counted. An
antibody specific to activated caspase 3 was used that detects the
large (17 kDa) fragment but that does not recognize either the full-
length procaspase-3 or other cleaved caspases. One-way ANOVA
identified a significant intervention effect (F3,20=8.3; p,0.01) and
post-hoc analysis revealed fewer cells positive for activated caspase
3 following AOX (p,0.01), ENR (p,0.01) and ENR/AOX
(p,0.001) treatment relative to aged controls. The greatest
reduction occurred with the combined treatment, which reduced
counts of activated caspase-3 positive cells by 80% relative to
untreated control values (Fig. 1). Double labeling of activated
caspase 3 with the neuronal marker NeuN (Fig. 2a) and the glial
marker GFAP (Fig. 2b) revealed that the majority of cells positive
for activated caspase-3 were also NeuN positive. These data
demonstrate that activated caspase 3 is present in the aged dog
frontal cortex, particularly in neurons, and that ENR and AOX
Figure 1. Immunohistochemical staining for caspase 3 in aged canine brains. a) Caspase 3 immunohistochemical staining in frontal cortices
of aged dogs treated with AOX and/or ENR interventions showed significant reduction in expression of active caspase 3. **p,0.01,***p,0.001. CON:
control environment/control diet; AOX: control environment/antioxidant diet; ENR: behavioral enrichment/control diet; AOX/ENR: behavioral
enrichment/antioxidant diet b) representative images of caspase 3 staining in frontal cortices.
doi:10.1371/journal.pone.0024652.g001
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potentially harmful protease is activated.
Lower levels of activated caspase 3 activity correlate with
better discrimination learning
We next evaluated if the extent of caspase 3 activation related to
cognitive performance, with the prediction that better cognition
would be present in those animals where fewer cells contained
activated caspase 3. To determine whether caspase activation was
correlated with cognitive function, we used behavioral data from
our previously published findings [5].
We selected a task that engages frontal lobe function (black/
white discrimination learning and reversal) and that was
conducted at the end of the 2.8 yr intervention period [5], so
that the molecular state would correspond closely to that present at
the time of testing. Plotting cognitive scores (errors in reversal
learning) and abundance of cells expressing activated caspase 3
revealed a strikingly parallel relationship between these 2 variables
in each animal (fig. 3a). Indeed, Pearson analysis identified a
robust correlation (r=0.76, p,0.01) across the 24 dogs (control,
ENR, AOX, ENR/AOX) (Fig. 3b). These results suggest that
beneficial effects of the interventions on cognitive function may be
related to reduced abundance of activated caspase 3.
Activated caspase 3 is associated with increased levels of
caspase-3 cleavage products
We next evaluated levels of casapase-3 cleavage products to
confirm that reduced immunoreactivity for activated caspase 3
with the interventions also reduced downstream proteolytic
consequences. Two well-characterized cleavage targets of caspase
3 are the cytoskeletal proteins beta-actin and tau. Specifically,
activated caspase-3 cleaves beta-actin between Asp244 and
Gly245, generating a 32 kDa N-terminal fragment of actin known
as Fractin, while tau is cleaved at the D421 site (tau421). Using an
activity test followed by dot-blot analysis, we confirmed that
caspase 3 cleaves tau to produce tau421 in canine frontal cortex
homogenates (data not shown), similar to the effect of caspase 3 on
tau in human and rodent brain tissue.
Frontal cortex sections were immunolabeled with an antibody
specific to fractin and cell counts were assessed in CON, AOX,
ENR and AOX/ENR groups. One-way ANOVA revealed a
significant treatment effect (F3,20=3.30, p,0.05), with modest
reductions in fractin-positive cells in the AOX and ENR groups
and a significant reduction to 40% of untreated controls in the
ENR/AOX combined treatment group (p,0.05) (Figs. 4a, b).
Double-labeling experiments revealed colocalization of fractin and
active caspase 3 in several cells in the frontal cortex (Fig. 5). Dot
blot assays were used to assess if levels of tau421 were similarly
affected by the interventions. One-way ANOVA revealed a
significant main effect (F3,20=3.52, p,0.05), with tau421 levels
reduced by 30% relative to untreated control levels with AOX
(p,0.05) and AOX/ENR intervention (p,0.05), and a non-
significant 22% decrease following ENR alone (data not shown).
In addition, Pearson correlation revealed that abundance of active
caspase 3 correlated with levels of both tau421 (r=.53, p,0.01),
and fractin (r=0.7, p,0.001). Taken together, these data indicate
that activation of caspase 3 and subsequent cytoskeletal protein
degradation are reduced in the frontal cortex of aged dogs
following AOX and ENR interventions, with the most robust
effect in the combined ENR/AOX treatment group.
Activation of caspase 9, but not caspase 8, is reduced by
the interventions
Because caspase 3 is primarily activatedby two initiatorpathways
driven by caspases 8 and 9, we next investigated if either of these
caspases may be a mechanism by which the dietary and behavioral
interventions reduce caspase 3 activation. Immunohistochemistry
using an antibody specific to activated caspase 8 revealed the
Figure 2. Double labeling with caspase 3 and neuronal or glial markers. a) Double labeling of activated caspase 3 with the neuronal marker
NeuN and b) the glial marker GFAP revealed that the majority of cells positive for activated caspase-3 were also NeuN positive.
doi:10.1371/journal.pone.0024652.g002
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however the incidence of immune-positive cells was rare. Activated
caspase-3 was detected in all groups, suggesting that the effects of
the dietary and behavioral interventions on caspase 3 activation are
not mediated via caspase 8. On the other hand, the interventions
reduced caspase 9 activation, based on counts of cells immunopo-
sitive for active caspase 9 and semaphorin 7A, a specific cleavage
product of active caspase 9. One-way ANOVA revealed a
significant treatment effect on cells positive for active caspase 9
(F3,18=4.85, p=0.016, Fig. 6a). Relative to untreated aged
controls, activated caspase 9 positive cell counts were reduced by
45% with AOX (p,0.05) and 50% with AOX/ENR (p,0.05)
intervention, with a non-significant 19% decrease with ENR alone.
Further, one-way ANOVA of semaphorin-7a positive cell counts
revealed a significant treatment effect of the interventions on the
cleavage product of caspase 9 (F3,20=4.98, p=0.013). Relative to
Figure 4. Activation of caspase 3 is associated with increased levels of caspase-3 cleavage products. a) Fractin immunohistochemical
staining in frontal cortices of aged dogs treated with AOX and/or ENR interventions showed significant reduction in expression of active caspase 3 in
the E/A group *p,0.05. CON: control environment/control diet; AOX: control environment/antioxidant diet; ENR: behavioral enrichment/control diet;
AOX/ENR: behavioral enrichment/antioxidant diet b) representative images of fractin staining in frontal cortices.
doi:10.1371/journal.pone.0024652.g004
Figure 3. Lower levels of activated caspase 3 activity correlate with better discrimination learning. a) Parallel relationship between
cognitive scores (errors in reversal learning) and abundance of cells expressing activated caspase 3 in each animal b) Caspase 3 expression is directly
correlated with errors in reversal learning. Pearson analysis r=0.76, p,0.01.
doi:10.1371/journal.pone.0024652.g003
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reduced 50% following AOX (p=0.017) and 42% with the
combined AOX/ENR (p,0.05) intervention, with a smaller
(25%) non-significant decrease with ENR alone (Fig. 6b, c). Overall,
these data indicate that caspase 9 activity was reduced with
interventions containing an AOX arm, with little additional effect
from the behavioral intervention, and suggest that reductions in
activation of caspase 9, but not caspase 8, may account in part for
decreased caspase 3 activation with the dietary intervention.
Effect of ENR and AOX on ceramide mobilization
The sphingolipid ceramide can disrupt the mitochondrial
respiratory chain, activate caspases and has been implicated in
signaling pathways that impair learning and memory. In
particular, increases in the levels of ceramide species in brain
and plasma were linked to cognitive impairment/decline in AD/
MCI [17,25]. To determine the effect of our interventions on
ceramide levels, we assessed levels of several species of ceramides
(14:0, 16:0, 18:0, 24:1) in the aged dog brain. The ceramide
species d18:1/18:0 and d18:1/14:0 showed treatment effects
(F3, 20=3.08, p,0.05, Fig. 7a), with the strongest effect occurring
with ENR alone. For the 18:0 species (F3, 20=3.08, p,0.05,
Fig. 7), ENR reduced levels to 61% of untreated control levels
(p,0.05). Similarly, the significant treatment effect on the 14:0
species was due to decreased levels with ENR treatment to 63% of
untreated control levels (p=0.014). No significant treatment effect
was found for the other ceramide species (Table 1). Unexpectedly,
there was no effect of AOX alone or combined AOX/ENR
treatment on any ceramide species. These results suggest that
AOX intervention does not affect ceramide generation, while
ENR induces specific changes in cellular ceramide levels.
Caspase 3 activation is not accompanied by apoptosis:
TUNEL labeling
While caspase activation has traditionally been associated with
apoptosis, recent findings reveal that activated caspase 3 can be
present in the brain with no evidence of cell death. To determine if
caspase 3 activation in the aged dog frontal cortex is accompanied
by apoptosis, we used TUNEL-labeling to detect the DNA
fragmentation characteristic of apoptotic cells. Interestingly, while
extensive TUNEL-positive labeling was apparent in the positive
control tissue (from a patient who had died from AD), no TUNEL-
positive cells were identified in any of the four treatment groups of
aged dogs, suggesting that activation of caspase 3 is not sufficient
to trigger cell death in the aged canine brain.
Discussion
Behavioral lifestyle interventions represent a quietly emerging
revolution in the modern approach to counteracting age-related
declines in brain health and cognitive function. In this study, we
investigated if activation of caspases and ceramide accumulation
are reduced by long term dietary and behavioral interventions.
Caspase activation and ceramide accumulation are common
convergence points for oxidative damage and AB, among other
factors associated with the aged and AD brain. While activated
caspases and ceramides are present in the AD brain and are
known risk factors for cognitive decline and neurodegeneration, no
studies to date have assessed if these are targeted by ENR, AOX or
combined intervention using higher animal models of human
brain aging.
Our data reveal a high abundance of cells with activated
caspase 3 in the frontal cortex of the aged dog brain, present
primarily in neurons. In parallel, caspase cleavage products, such
as cleaved cytoskeletal proteins actin and tau are present. A
sustained change in lifestyle consisting of behavioral enrichment,
dietary supplementation with antioxidants and mitochondrial
cofactors, or the combined intervention dramatically reduced the
abundance of cells expressing activated caspase 3, with the
combined intervention having the greatest effect, reducing
numbers of immune-positive cells by 80% relative to untreated
levels. The reduction in active caspase 3 correlated strongly with
Figure 5. Double-labeling detected by immunofluorescence revealed colocalization of fractin and active caspase 3 in several cells
in the frontal cortex.
doi:10.1371/journal.pone.0024652.g005
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immunohistochemical staining in frontal cortices of aged dogs treated with AOX and/or ENR interventions showed significant reduction in expression
of active caspase 9 in the AOX and combined treatment groups *p,0.05. b) Expression of semaphorin 7a, was reduced in frontal cortices of aged
dogs in the AOX (**p,0.01) and AOX/ENR (p,0.05) groups. c) Representative images of semaphorin 7a staining in frontal cortices of CON and AOX/
ENR groups.
doi:10.1371/journal.pone.0024652.g006
Figure 7. Effect of ENR and AOX on ceramide mobilization. a) Levels of total ceramides in the frontal cortices of aged dogs treated with AOX
and/or ENR interventions showed significant reduction in ENR group only (p,0.05). b) Representative LC/MS chromatogram of the unnatural
ceramide d18:1/12:0 (Cer 12:0, used as an internal standard, IS) and the endogenous ceramide d18:1/18:0 (Cer 18:0) extracted from canine frontal
cortex.
doi:10.1371/journal.pone.0024652.g007
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reduction in caspase 3 activation is an important target of the
interventions to promote cognitive stability with age. In parallel
with fewer cells expressing active caspase-3, there were fewer cells
expressing caspase cleavage products, including fractin and
cleaved tau, which may underlie the benefits of reduced caspase
3 activation. For example, the truncation state of tau influences
many of its normal and pathologic characteristics, including its
ability to bind to and stabilize microtubules [26,27] and thereby
may compromise axonal flow and intracellular trafficking. Taken
together, these data suggest that reduced caspase 3 activation is
likely to be an important mechanism underlying benefits of the
interventions on maintaining cognitive function with age.
Caspase 3 is traditionally known as one of the primary effector
caspases driving apoptosis. However, our finding that activated
caspase 3 is not accompanied by TUNEL labeling strongly
suggests that caspase activation in the canine brain is associated
with non-apoptotic processes. This is supported by our previous
finding that neuron loss in the aged canine brain is minimal [28],
consistent with the general absence of cortical neuronal loss in
normal human brain aging [29]. Further, reports of active caspase
3 in absence of apoptosis have recently emerged. For example, in
olfactory sensory neurons, caspases 3 and 9 are activated without
cells undergoing histone H1 changes or apoptotic morphology
[30]. Similarly, activated caspases (including caspase 3) are present
in cortical neurons of transgenic mouse models of AD in the
absence of cell death [31]. These findings indicate that activated
caspase 3 can be dissociated from apoptosis, and may be linked to
other cellular processes. Indeed, recent findings demonstrate that
activate caspase 3 is a key factor impairing synaptic function. For
example, an up-regulation of caspase 3 mediates the inhibition of
long term potentiation (LTP) by Ab1–42 [13] and synaptic
dysfunction [14]. Taken together, these findings suggest that
reducing caspase 3 activation is beneficial to synaptic health and
neuronal function, and may be an important mechanism targeted
by the dietary and behavioral interventions to improve cognitive
function.
While activation of caspase 3 is regulated primarily by the
initiator caspases 8 and 9, our data suggest that only caspase 9
activation is targeted by the interventions. Active caspase 8 was
present but sparse in the aged frontal cortex, and was detected in
all treatment groups. In contrast, many cells were immunopositive
for active caspase 9, with animals treated with an AOX arm (eg
AOX, or AOX/ENR) showing approximately 50% fewer cells
expressing active caspase 9 or its cleavage product semaphorin 7A.
Because caspase 9 is selectively released by stressed mitochondria
these findings suggest that mitochondrial health is improved by the
interventions, consistent with our previous finding that the
antioxidant diet reduced mitochondrial ROS production and
improved NADH respiration in the canine [32].
Like caspase 3, the bioactive lipid group of ceramides has
recently been identified as potential causes of cognitive decline and
onset of AD. Levels of ceramides have been shown to be elevated
in the cerebral cortex during normal aging and in Alzheimer’s
disease [33]. It has been hypothesized that the harmful effects of
ceramide are caused by suppression of the mitochondrial
respiratory chain, with resulting ROS production and oxidative
stress [20]. Because our previous data demonstrated that the AOX
diet reduced mitochondrial ROS production and improved
NADH respiration in the canine [32]we hypothesized that a
reduction in ceramide might be one mechanism targeted by the
dietary intervention. Unexpectedly, the AOX diet, either alone or
combined with ENR, did not reduce ceramide levels in the aged
cortex, contrasting with the pronounced declines in caspase 3
activation with the combined intervention. These data indicate
that the reduction in caspase 3 activation with the interventions is
not tightly linked to ceramide levels in the aged dog brain. Finally,
the finding that ceramide levels were reduced with behavioral
enrichment alone suggests that behavioral intervention can
improve cellular health by pathway(s) distinct from those engaged
by the dietary interventions. Ceramide reduction with behavioral
enrichment may contribute to the cognitive benefits derived from
ENR alone.
Taken together, our findings reveal that life style interventions
can engage a range of molecular mechanisms to improve brain
health and cognitive function. Along with our previous findings
that behavioral and dietary interventions improve mitochondrial
NADH respiration, reduce generation of mitochondrial reactive
oxygen species (ROS) [8] lower levels of protein carbonyls, and
bolster antioxidant defense mechanisms in the brain [9] and
increase levels of brain-derived neurotrophic factor (BDNF), [34],
we demonstrate here that these interventions attenuate caspase 3
activation in the aged frontal cortex. In addition to decreasing
harmful factors that accumulate with age and impair neuronal
health and function, lifestyle interventions increase factors that are
protective and promote plasticity. Since many of these mecha-
nisms decrease caspase 3 activation [35,36] these data support the
idea that regulation of caspase 3 activation may be an important
convergence point for multiple pathways activated by lifestyle
interventions. Overall, these data are the first to show that lifestyle
interventions can regulate caspase pathways in a higher animal
model of human brain aging.
Materials and Methods
Subjects
Twenty-four beagles ranging in age at the start of the study from
8.05 to 12.35 years (mean=10.69 years, SE=0.25, 12 males/12
females) were obtained from the colony at the Lovelace
Respiratory Research Institute. Animals were born and main-
tained in the same environment and all had documented dates of
birth and comprehensive medical histories.
Ethics Statement
All studies were conducted in compliance with approved
IACUC protocols, consistent with the National Research Coun-
cil’s Guide for the care and use of laboratory animals.
Group assignments and study timeline
All dogs underwent extensive baseline cognitive testing as has
been described previously [32,37]. Based on cognitive test scores,
Table 1. Table showing levels of individual ceramide species
as measured by LC/MS in the frontal cortices of aged dogs
treated with dietary or behavioral interventions.
CON AOX ENR AOX/ENR
Cer d18:1/14:0 0.0660.001 0.00660.002 0.00460.001 0.01060.005
Cer d18:1/16:0 0.2060.02 0.2460.07 0.17060.02 0.19660.02
Cer d18:1/18:0 6.0560.55 5.0060.90 3.70160.39 5.95160.53
Cer d18:1/24:1 0.1260.02 0.1460.03 0.12660.02 0.12960.19
Data expressed as 6SEM. CON: control environment/control diet; AOX: control
environment/antioxidant diet; ENR: behavioral enrichment/control diet; AOX/
ENR: behavioral enrichment/antioxidant diet.
doi:10.1371/journal.pone.0024652.t001
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one of four treatment groups such that each group contained
animals with equivalent ranges of cognition (e.g. poor to good):
control environment/control diet (CON), enriched environment/
control diet (ENR), control environment/antioxidant diet (AOX),
enriched environment/antioxidant diet (ENR/AOX).
Behavioral enrichment
The behavioral enrichment protocol has been described
previously [32] and consisted of housing animals in pairs (social
enrichment), providing 2–20 min outdoor walks per week
(physical exercise), and continuous cognitive testing (cognitive
enrichment). The cognitive enrichment consisted of a landmark
discrimination task [38], an oddity discrimination task [39], and a
size discrimination learning and reversal task [5,40].
Diet
Both the control and supplemented test foods were formulated
to meet the nutrient profile for the American Association of Feed
Control Officials (AAFCO) recommendations for adult dogs
(AAFCO 1999) and has been described previously [32]. Control
and test foods were identical in composition, with the exception
that the test diet contained a broad-based antioxidant and
mitochondrial cofactor supplementation. The control and en-
riched foods had the following differences in formulation on an as-
fed basis, respectively: dl-alpha-tocopherol acetate, (120 ppm vs
1050 ppm), l-carnitine (,20 ppm vs 260 ppm), dl-alpha-lipoic
acid (,20 ppm vs 128 ppm), ascorbic acid as Stay-C (,30 ppm vs
80 ppm), and 1% inclusions of each of the following (1-to-1
exchange for corn): spinach flakes, tomato pomace, grape pomace,
carrot granules, and citrus pulp.
Tissue Preparation
Dogs were ex-sanguinated under anesthesia (5% isoflurane), by
cardiac puncture and within 15 min the brain was removed from
the skull. The brain was sectioned midsagitally, with the entire left
hemisphere being immediately placed in 4% paraformaldehyde
for 48–72 h at 4uC then transferred to phosphate buffered saline
with 0.05% sodium azide at 4uC for long term storage. The left
hemisphere was sent to NeuroScience Associates for sectioning.
NeuroScience Associates treated individual canine hemispheres
with 20% glycerol and 2% dimethylsulfoxide to prevent freeze-
artifacts and subsequently embedded two hemispheres (i.e. two
animals) per block in a gelatin matrix using MultiBrain
Technology
TM (NeuroScience Associates, Knoxville, TN; http://
www.neuroscienceassociates.com/multibrain.htm). The Multi-
Brain
TM block was sectioned coronally at 40 mm. All sections
cut (none were discarded) were collected sequentially into a 466
array of containers which were filled with Antigen Preserve
solution (50% PBS pH 7.0, 50% ethylene glycol, 1% polyvinyl
pyrrolidone) for sections to be immunohistochemically stained. At
the completion of sectioning, each container held a serial set of
one-of-every-24th section (or one section every 960 mm), with
approximately 1400 sections generated per hemisphere. One
container of free-floating sections was randomly selected per dog
and all sections in that container that frontal cortex were collected
for immunohistochemical staining.
Immunohistochemistry
Standard immunohistochemical methods were used and have
been published elsewhere [40,41]. The following primary
antibodies were used: active caspase 3 (1:100; chemicon), active
caspase 8 (1:200), active caspase 9 (1:100; abcam), semaphorin 7A
(1:100; abcam), caspase-cleaved tau (1:1000; generously supplied
by L Binder), fractin (1:500; chemicon), xIAP (1:200;Abcam).
Bound secondary biotinylated IgG (Vector Laboratories, Burlin-
game, CA) was detected using ABC peroxidase kits from Vector
Laboratories (Burlingame, CA). Free-floating sections were mount-
ed onto gelatin coated slides, dehydrated through ethanols and
coverslipped with DePeX mounting medium. One section from
each of the 24 dogs was stained in each immunohistochemistry run.
Control experiments where primary or secondary antibody was
omitted resulted in negative staining. Complete penetration of the
antibodies was confirmed by detection of labeled cells in all deeper
layers within a section. For quantification of staining, total numbers
of labeled cells were counted in at least three different sites from
each section, using a light microscope at 206magnification.
Immunofluorescent double labeling
Immunofluorescence was used to evaluate colocalization of
cleaved caspase 3 (1:100) with either NeuN (1:500) or GFAP
(1:1000). The primary antibody/antigen complex was detected
using secondary antibodies conjugated to either Alexa 488 or
Alexa 568 (Invitrogen), and was visualized using a Zeiss LSM510
META confocal system configured with a Zeiss Axiovert 200 M
motorized inverted microscope. Multilabeled fluorescent samples
were imaged acquiring each fluorescent channel sequentially to
avoid signal bleed-over. The Alexa 488 component was obtained
using the 488 nm line of an argon ion laser for excitation and a
band pass 505–530 nm emission filter. The Alexa 564 component
was obtained using the 543 nm line of a green helium/neon laser
for excitation and a band pass 585–620 nm emission filter.
Dot blot assay
Nitrocellulose membranes were dotted with 1 ml of frontal
cortical crude extracts (4 ug/ul) from 4 aged beagles. All extracts
were suspended in 100 ml of Laemmli buffer prior to absorption on
the membrane. The membrane was air dried for 30 minutes and
blocked with TBS-5% BSA and incubated with caspase cleaved
tau antibody (1:1000, overnight at 4uC). After three washes with
TBS-0.05% Tween 20, the immune complexes were revealed with
HRP-labeled goat anti-mouse secondary antibody (Sigma) (1/
10,000 dilution, 1 hour at room temperature) followed by ECL
detection. In addition, to detect caspase 3-induced cleavage of tau
in crude frontal cortex homogenates, an activity test was
performed. Specifically, wells were coated with 1 ml of active
caspase-3 protease (Chemicon) and incubated with frontal cortex
homogenates (1 ml, 4 ug/ul) from 4 aged beagles at 37uC for
1 hour. A dot blot assay to detect cleaved tau was then performed
on the samples as described above.
Ceramide analyses
Lipid extractions analysis was conducted as previously described
[42]. Briefly, frozen tissue samples were weighed and homoge-
nized in cold methanol containing appropriate authentic standards
(listed below). Total lipids were extracted by adding chloroform
and water (2/1, vol/vol) and fractionated through open-bed silica
gel columns by progressive elution with chloroform/methanol
mixtures. Fractions eluted from the columns were dried under
nitrogen, reconstituted in chloroform/methanol (1:4, vol/vol;
0.1 ml) and subjected to liquid chromatography/mass spectrom-
etry. Ceramides were analyzed by tandem mass spectrometry,
using an Agilent 1100 liquid chromatograph coupled to an ESI-
ion-trap XCT mass detector. Ceramide molecular species were
separated on a Poroshell 300 SB C18 column (2.1675 mm i.d.,
5 mm; Agilent Technologies) maintained at 30uC. A linear
gradient of methanol in water containing 5 mM ammonium
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3 min) was applied at a flow rate of 1 ml/min. Detection was in
the positive mode, capillary voltage was 4.5 kV, skim1 240 V,
and capillary exit 2151 V. Nitrogen was used as drying gas at a
flow rate of 12 L/min, temperature of 350uC, and nebulizer
pressure of 80 psi. Helium was used as collision gas. Ceramide
species were identified by comparison of its LC retention time and
MSn fragmentation pattern with that of authentic standards
(Avanti Polar Lipids). Extracted ion chromatograms were used to
quantify the following ceramides: d18:0/14:0 [M+H]
+ (m/z=
510.5.492.5.264.3), d18:1/16:0 [M+H]
+ (m/z=538.5.
520.5.264.3), d18:1/18:0 [M+H]+ (m/z=566.5.548.5.
264.3), d18:1/24:1 [M+H]
+ (m/z=648.6.630.8.264.3), using
d18:1/12:0 [M+H]
+ (m/z=482.5.464.5.264.3) as an internal
standard.
Terminal dUTP Nick-end Labeling and Staining
Apoptotic cells can be detected by terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP nick end labeling (TUNEL).
Using slide-mounted tissue sections, DNA fragmentation was
detected using a TUNEL labeling apoptosis detection kit
(Chemicon) according to the manufacturer’s instruction. As a
positive control, a brain section from a patient who had died from
AD was included.
Statistical analysis
To quantify immunohistochemical staining, numbers of labeled
cells were counted in at least three different sites from each frontal
cortex section, using a light microscope at 206magnification. For
each section, values from the multiple sites were averaged to
generate a single mean value per dog. Average and standard error
of the mean (n=5–6 per group) were then generated for each
treatment group. Dot blots were quantified by using Image J
software and the intensity of the dots are expressed as optical
density (OD). Statistical analysis on immunopositive cell counts,
dot blot intensity, and ceramide levels consisted of one-way
ANOVA across the 4 treatment groups to detect a main effect of
intervention, followed by post-hoc bonferroni t-test (p,0.05) if a
significant main effect was detected.
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